These GzmK+CD8+T cells in the lungs further exacerbate the inflammatory symptoms of asthma via their GzmK-dependent proteolytic functions and CS activation (Figure 5), which was restored in animals treated with anti-GzmK drugs or not seen in GzmK KO mice subjected to asthma [314]. This evidence concerns the gene CD8A and asthma.